Amgen (AMGN) Debt to Equity (2009 - 2026)
Amgen's quarterly Debt to Equity came in at $6.24 in Q1 2026, down 32.53% year-on-year from $9.24 in Q1 2025, and down 1.1% quarter-over-quarter from $6.31 in Q4 2025.
Amgen has reported Debt to Equity for 18 years, with the latest figure at $6.24 in Q1 2026.
- For the quarter ending Q1 2026, Debt to Equity fell 32.53% year-over-year to $6.24; the trailing twelve-month figure through Mar 2026 stood at $6.24 (down 32.53% YoY), and the FY2025 full-year result was $6.31, down 38.33% from the prior year.
- Debt to Equity for Q1 2026 stood at $6.24, down from $6.31 in the prior quarter.
- The five-year high for Debt to Equity was $40.23 in Q1 2022, with the low at $5.67 in Q3 2025.
- Average Debt to Equity over 5 years is $11.3, with a median of $10.23 recorded in 2024.
- Year-over-year, Debt to Equity soared 1048.97% in 2022 and tumbled 71.37% in 2023.
- Tracing AMGN's Debt to Equity over 5 years: stood at $10.64 in 2022, then retreated by 2.54% to $10.37 in 2023, then declined by 1.37% to $10.23 in 2024, then plunged by 38.33% to $6.31 in 2025, then fell by 1.1% to $6.24 in 2026.
- The last three Debt to Equity figures came in at $6.24 (Q1 2026), $6.31 (Q4 2025), and $5.67 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 1.39 |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 0.68 |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | -9.70 |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 1.07 |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 6.24 |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 0.94 |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 0.72 |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 2.22 |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 1.08 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.24 |
| Dec 31, 2025 | 6.31 |
| Sep 30, 2025 | 5.67 |
| Jun 30, 2025 | 7.57 |
| Mar 31, 2025 | 9.24 |
| Dec 31, 2024 | 10.23 |
| Sep 30, 2024 | 8.02 |
| Jun 30, 2024 | 10.57 |
| Mar 31, 2024 | 12.75 |
| Dec 31, 2023 | 10.37 |
| Sep 30, 2023 | 7.90 |
| Jun 30, 2023 | 9.08 |
| Mar 31, 2023 | 11.52 |
| Dec 31, 2022 | 10.64 |
| Sep 30, 2022 | 10.60 |
| Jun 30, 2022 | 15.10 |
| Mar 31, 2022 | 40.23 |
| Dec 31, 2021 | 4.97 |
| Sep 30, 2021 | 4.57 |
| Jun 30, 2021 | 3.98 |
| Mar 31, 2021 | 3.50 |
| Dec 31, 2020 | 3.51 |
| Sep 30, 2020 | 3.13 |
| Jun 30, 2020 | 3.21 |
| Mar 31, 2020 | 3.36 |
| Dec 31, 2019 | 3.09 |
| Sep 30, 2019 | 2.73 |
| Jun 30, 2019 | 2.84 |
| Mar 31, 2019 | 3.05 |
| Dec 31, 2018 | 2.71 |
| Sep 30, 2018 | 2.40 |
| Jun 30, 2018 | 2.31 |
| Mar 31, 2018 | 2.28 |
| Dec 31, 2017 | 1.40 |
| Sep 30, 2017 | 1.11 |
| Jun 30, 2017 | 350.62 |
| Mar 31, 2017 | -94.18 |
| Dec 31, 2016 | 1.16 |
| Sep 30, 2016 | 1.15 |
| Jun 30, 2016 | 117.81 |
| Mar 31, 2016 | 290.74 |
| Dec 31, 2015 | 1.12 |
| Sep 30, 2015 | 1.14 |
| Jun 30, 2015 | 1.16 |
| Mar 31, 2015 | 1.14 |
| Dec 31, 2014 | 1.19 |
| Sep 30, 2014 | 1.30 |
| Jun 30, 2014 | 1.37 |
| Mar 31, 2014 | 1.30 |
| Dec 31, 2013 | 1.45 |
| Sep 30, 2013 | 1.25 |
| Jun 30, 2013 | 1.16 |
| Mar 31, 2013 | 1.23 |
| Dec 31, 2012 | 1.26 |
| Sep 30, 2012 | 1.21 |
| Dec 31, 2011 | 1.12 |
| Mar 31, 2010 | 0.42 |
| Dec 31, 2009 | 0.27 |
| Sep 30, 2009 | 0.27 |
| Jun 30, 2009 | 0.29 |